Is Mesoblast Ltd (MESO) Stock at the Top of the Biotechnology Industry?

Wednesday, November 30, 2022 11:21 AM | InvestorsObserver Analysts

Mentioned in this article

Is Mesoblast Ltd (MESO) Stock at the Top of the Biotechnology Industry?

The 68 rating InvestorsObserver gives to Mesoblast Ltd (MESO) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 84 percent of stocks in the Biotechnology industry, MESO’s 68 overall rating means the stock scores better than 68 percent of all stocks.

MESO has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on MESO!

See Full MESO Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Mesoblast Ltd Stock Today?

Mesoblast Ltd (MESO) stock is up 11.87% while the S&P 500 is lower by -0.19% as of 10:53 AM on Wednesday, Nov 30. MESO is higher by $0.38 from the previous closing price of $3.20 on volume of 151,307 shares. Over the past year the S&P 500 is down -13.51% while MESO is lower by -40.83%. MESO lost -$0.65 per share the over the last 12 months. Click Here to get the full Stock Report for Mesoblast Ltd stock.